Clinical Trials on Unilateral Ovarian Endometrioma in China
Total 525 results
-
Shanghai First Maternity and Infant HospitalShanghai Tongji Hospital, Tongji University School of Medicine; International...RecruitingOvarian Reserve | Ovarian EndometriomaChina
-
Fudan UniversityWithdrawnEndometrial Endometrioid AdenocarcinomaChina
-
Peking University Third HospitalCompletedPCOS (Polycystic Ovary Syndrome) of Bilateral OvariesChina
-
Hua LiRecruiting
-
Fudan UniversityRecruitingDepression, Anxiety | PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesChina
-
Peking Union Medical College HospitalMerck Serono International SACompletedPostmenopausal EndometriumChina
-
Affiliated Hospital of Nantong UniversityEnrolling by invitationT2D | PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesChina
-
Heilongjiang University of Chinese MedicineCompletedEndometrium; SenilityChina
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Ovarian Carcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Uterine Corpus Cancer | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Ovarian Endometrioid AdenocarcinomaUnited States
-
Nanjing UniversityUnknown
-
Gui XiaotingRecruitingPCOS (Polycystic Ovary Syndrome) of Bilateral OvariesChina
-
Multitude Therapeutics Inc.Tigermed Consulting Co., LtdRecruitingOvarian Cancer | Ovarian Epithelial Cancer | Lung Adenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Advanced Cancer | Ovarian Clear Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial... and other conditionsChina, Australia
-
Chinese PLA General HospitalRecruitingUnilateral DeafnessChina
-
Xiaojun ChenRecruitingOverweight | Fertility Issues | Obese | Endometrial CarcinomaChina
-
Lei LiUnknownEndometriosis | Adenomyosis | Genomics | Metabolomics | Ectopic Endometrium | Eutopic Endometrium | TranscriptomicsChina
-
Sun Yat-sen UniversityNot yet recruitingOvarian Cancer | Primary Peritoneal Cancer | High Grade Serous Adenocarcinoma of Ovary | High Grade Endometrioid Ovarian Cancer | Fallopian-tube CancerChina
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Fallopian... and other conditionsUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Mucinous... and other conditionsUnited States, Korea, Republic of, Japan
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingRecurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Endometrial Serous Adenocarcinoma | Recurrent Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell... and other conditionsUnited States, Canada
-
Lei LiRecruitingEpithelial Ovarian Cancer | Microsatellite Instability | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Peking University People's HospitalPeking Union Medical College Hospital; Peking University Third Hospital; Tongji... and other collaboratorsRecruitingEndometrial Neoplasms | Carcinoma, Endometrioid | Fertility Preservation | Endometrial Neoplasm Malignant Stage I | Endometrial Neoplasm MalignantChina
-
Nanjing UniversityUnknownInfertile High-risk Patients With Polycystic OvariesChina
-
Sir Run Run Shaw HospitalUnknown
-
Sir Run Run Shaw HospitalCompletedIntrauterine Adhesion | Thin EndometriumChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Completed
-
Health Science Center of Xi'an Jiaotong UniversityRecruitingOvarian Cancer | Cancer of the Ovary | Ovarian Neoplasm | Ovary Cancer | Neoplasms, Ovarian | Ovary Neoplasms | Ovary Neoplasm | Cancer of Ovary | Cancer, Ovarian | Ovarian Cancers | Neoplasm, Ovarian | Neoplasm, Ovary | Neoplasms, Ovary | Cancer, Ovarian Stromal | Cancers, Ovary | Ovary Cancers | Cancers, OvarianChina
-
Tongji HospitalRecruiting
-
The First Affiliated Hospital of Anhui Medical...National Research Institute for Family Planning, ChinaRecruitingPrimary Ovarian Insufficiency | Premature Ovarian Failure | Diminished Ovarian Reserve | Ovarian DysgenesisChina
-
Tongji HospitalRecruiting
-
Peking University Third HospitalRecruitingDiminished Ovarian ReserveChina
-
Shi YunCapital Medical UniversityNot yet recruiting
-
Peking University People's HospitalBeijing Weixiao Biotechnology Development LimitedRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian CancerChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Liquid Biopsy | DNA Methylation | Benign Ovarian Tumor | Training Set | Validation Set | Cell-free DNAChina
-
Shanghai East HospitalAnhui Provincial Hospital; Nanjing Legend Biotech Co.; East Clinical Center of...Terminated
-
Jun ZhangCompletedAdvanced Ovarian CancerChina
-
RenJi HospitalCompletedEpithelial Ovarian CancerChina
-
Tongji HospitalNot yet recruitingDiminished Ovarian ReserveChina
-
Peking University Third HospitalRecruitingDiminished Ovarian Reserve | Premature Ovarian InsufficiencyChina
-
ShangHai Ji Ai Genetics & IVF InstituteCompleted
-
GeneScience Pharmaceuticals Co., Ltd.Peking University People's Hospital; Peking University Third HospitalUnknown
-
Lei LiRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound PaclitaxelChina
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Huazhong University of Science and TechnologyRecruitingDecreased Ovarian ReserveChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Progression-free Survival | Epithelial Ovarian Tumor of Borderline Malignancy | Driving MutationsChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma and other conditionsUnited States
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.RecruitingAdvanced Ovarian CancerChina
-
Peking Union Medical College HospitalUnknownEpithelial Ovarian CancerChina
-
Xinhua Hospital, Shanghai Jiao Tong University...WithdrawnPlatinum-resistant Ovarian CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Chen ChunlinChinese Academy of SciencesRecruitingCervical Cancer | Endometriosis | Uterine Sarcoma | Adenomyosis | Endometrial Carcinoma | Ovarian Tumor | Ovarian Cyst Benign | Uterine Myomatosis | Ovarian Cyst MalignantChina